A Mixed Probiotic/Prebiotic Intervention (MBR-01) for the Management of Diarrhea During Abemaciclib Treatment of Early Breast Cancer: A Single-Center Prospective Case–Control Pilot Study
D. Generali(Ospedale di Cattinara), Francesco Schettini(Target (United States)), Valeria Cervoni(University of Trieste), Carla Strina(Istituti Ospitalieri di Cremona), Alexandro Membrino(Istituti Ospitalieri di Cremona), Alessandra Fontana(Università Cattolica del Sacro Cuore), Federica Gattazzo(Università Cattolica del Sacro Cuore), Manuela Milani(Humanitas University), Sergio Del Bianco(Precision for Medicine (United States)), Andrea Castagnetti(Ospedale di Circolo di Busto Arsizio), Aldo Caltavituro(University of Naples Federico II)
Cited by 0
Related Papers
The Role of ATF4 Stabilization and Autophagy in Resistance of Breast Cancer Cells Treated with Bortezomib
|Cancer Research|2009|298
Hypoxia-Inducible Factor-1α Expression Predicts a Poor Response to Primary Chemoendocrine Therapy and Disease-Free Survival in Primary Human Breast Cancer
|Clinical Cancer Research|2006|244
Effects of Acute versus Chronic Hypoxia on DNA Damage Responses and Genomic Instability
|Cancer Research|2010|205
CDK 4/6 Inhibitors as Single Agent in Advanced Solid Tumors
|Frontiers in Oncology|2018|205
Role of ATF4 in regulation of autophagy and resistance to drugs and hypoxia
|Cell Cycle|2009|197